Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.
第一作者:
Kruti,Joshi
第一单位:
Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, USA.
作者:
医学主题词
投药, 口服(Administration, Oral);青少年(Adolescent);成年人(Adult);抗精神病药(Antipsychotic Agents);成本及成本分析(Costs and Cost Analysis);诊断, 双重(精神病学)(Diagnosis, Dual (Psychiatry));用药计划表(Drug Administration Schedule);女(雌)性(Female);卫生保健费用(Health Care Costs);卫生资源(Health Resources);住院(Hospitalization);人类(Humans);男(雄)性(Male);Medicaid(Medicaid);服药依从性(Medication Adherence);中年人(Middle Aged);回顾性研究(Retrospective Studies);精神分裂症(Schizophrenia);物质相关性障碍(Substance-Related Disorders);治疗结果(Treatment Outcome);美国(United States);青年人(Young Adult)
DOI
10.2217/cer-2017-0043
PMID
28809128
发布时间
2022-03-18
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



